Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?

U. Costabel
European Respiratory Review 2011 20: 201-207; DOI: 10.1183/09059180.00002011
U. Costabel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ulrich.costabel@ruhrlandklinik.uk-essen.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 20 no. 121 201-207
DOI 
https://doi.org/10.1183/09059180.00002011
PubMed 
21881148

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received February 15, 2011
  • Accepted March 3, 2011
  • Published online August 31, 2011.

Copyright & Usage 
©ERS 2011

Author Information

  1. U. Costabel⇓
  1. U. Costabel, Ruhrlandklinik Essen, Universitätsklinik, Tüschener Weg 40, 45239 Essen, Germany. E-mail: ulrich.costabel{at}ruhrlandklinik.uk-essen.de
View Full Text

Article usage

Article usage: August 2011 to July 2022

AbstractFullPdf
Aug 201127412
Sep 2011774118306
Oct 2011454106154
Nov 2011407195158
Dec 20111689584
Jan 201220991106
Feb 2012184142128
Mar 201221210982
Apr 201217410187
May 201215376102
Jun 201211510447
Jul 201210713158
Aug 201210412443
Sep 201212612067
Oct 201210724291
Nov 20129326190
Dec 20128718059
Jan 201318732370
Feb 20138220159
Mar 20136118850
Apr 20137513550
May 20135016182
Jun 20133612334
Jul 2013306834
Aug 2013184420
Sep 2013326522
Oct 2013315625
Nov 2013265418
Dec 2013192512
Jan 2014214025
Feb 2014235124
Mar 2014473331
Apr 2014294919
May 2014305519
Jun 20141214553
Jul 20141616929
Aug 2014208016
Sep 2014207024
Oct 2014215516
Nov 2014235012
Dec 201416479
Jan 2015154814
Feb 20158407
Mar 2015155613
Apr 2015226718
May 2015144623
Jun 2015174326
Jul 2015137215
Aug 2015174212
Sep 2015215419
Oct 201523713
Nov 201512517
Dec 20158507
Jan 201633219
Feb 20165245
Mar 2016309232
Apr 2016104417
May 201653624
Jun 201631318
Jul 201634339
Aug 20169249
Sep 2016244218
Oct 2016254915
Nov 201639507
Dec 201663820
Jan 20177296
Feb 20175163
Mar 201752810
Apr 201710158
May 201710333
Jun 20175193
Jul 201753616
Aug 20171296
Sep 20174538
Oct 2017113712
Nov 20171447
Dec 20172329
Jan 20188306
Feb 20182416
Mar 20182237
Apr 20183166
May 20180277
Jun 20180385
Jul 20180338
Aug 2018020111
Sep 201801535
Oct 201802487
Nov 2018126315
Dec 201802106
Jan 201901357
Feb 20191943
Mar 201928711
Apr 20193496
May 20191656
Jun 20191425
Jul 20190458
Aug 20190345
Sep 201946538
Oct 201915310
Nov 20191406
Dec 20190395
Jan 20200362
Feb 20200415
Mar 202011296
Apr 20201314
May 202034917
Jun 202015910
Jul 20201399
Aug 202004512
Sep 202008816
Oct 202016411
Nov 202004919
Dec 202024211
Jan 202104713
Feb 202113816
Mar 20212477
Apr 20210466
May 20212458
Jun 20210566
Jul 202135111
Aug 20211615
Sep 202119711
Oct 202117133
Nov 202114830
Dec 20210436
Jan 20221314
Feb 20221285
Mar 20223644
Apr 20220233
May 202213811
Jun 202212326
Jul 20221212

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 20 Issue 121 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
U. Costabel
European Respiratory Review Sep 2011, 20 (121) 201-207; DOI: 10.1183/09059180.00002011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
U. Costabel
European Respiratory Review Sep 2011, 20 (121) 201-207; DOI: 10.1183/09059180.00002011
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • PHARMACOLOGICAL THERAPIES FOR IPF: CURRENT STATUS
    • TRIPLE THERAPY WITH PREDNISONE, AZATHIOPRINE AND N-ACETYLCYSTEINE
    • PIRFENIDONE
    • JAPANESE PHASE II AND III TRIALS
    • STUDIES 004 AND 006: EUROPEAN AND NORTH AMERICAN PHASE III TRIALS
    • EXPLORATORY POOLED ANALYSIS OF STUDIES 004 AND 006
    • SAFETY AND TOLERABILITY OF PIRFENIDONE IN STUDIES 004 AND 006
    • META-ANALYSIS OF PHASE III STUDIES
    • PROGNOSTIC FACTORS FOR IPF AND ASSESSMENT OF NEW TREATMENT OPTIONS
    • SUMMARY
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society